Document is current
Any future updates will be listed below
-
Authors
McCaughey-Chapman, Amy https://orcid.org/0000-0002-3177-2658
Burgers, Anne Lieke
Combrinck, Catharina
Marriott, Laura
Gordon, David
Connor, Bronwen
-
Funding
Funding for this research was provided by:
Health Research Council of New Zealand (Health Research Council of New Zealand)
Auckland UniServices Limited Inventor Fund (Auckland UniServices Limited Inventor Fund)
Maurice and Phyllis Paykel Trust (Maurice and Phyllis Paykel Trust)
Hudson-Nilon Medical Research Trust (Hudson-Nilon Medical Research Trust)
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 8 November 2024
First Online: 22 November 2024
Declarations
:
: All animal procedures strictly complied with the University of Auckland Animal Ethics Guidelines, in accordance with the New Zealand Animal Welfare Act 1999 and international ethical guidelines. All efforts were made to minimize the number of animals used and their suffering. AEC R21614, approved 03/05/2021, for project entitled “Novel Cell Replacement Therapy for Huntington’s Disease”.
: All authors have provided written consent for publication.
: The authors declare no competing interests except for a provisionally filed patent International PCT filing AU2023902064; Cellular Reprogramming. Connor, B and Samuel, A.J.
